Biology to Prevention Award (CRUK) supports UK and U.S. research teams working together to translate biological insights into primary prevention approaches that could reduce cancer risk or incidence.
The ACS contact email for this UK–U.S. co-funding opportunity changed from Eligibility@cancer.org to grant.eligibility@cancer.org.
Biology to Prevention Award supports research teams studying biological mechanisms of cancer development and risk to develop precision approaches to primary prevention and ultimately reduce cancer incidence.
Advanced Clinical Research Award supports independent mid-career physicians pursuing original breast cancer clinical or human-subjects translational research to address patient needs and potential benefit.
CRI Clinic and Laboratory Integration Program supports investigator teams translating cancer immunology discoveries into immune-based approaches to prevent initial cancer development and recurrence.
The Biology of Early Onset Breast Cancer Initiative supports investigators and research teams studying why breast cancer develops in younger women and behaves differently, to inform prevention and care.
Clinical Cancer Research supports investigators conducting patient-centered cancer trials and early-detection studies to improve treatment options, enable earlier intervention, and enhance quality of life.